Intravenous Immunoglobulin (IVIg) for unexplained infertility: a case series

被引：0
|
作者：
Genest, G. [1 ]
Elliott, B. [2 ]
Spitzer, K. [3 ]
Laskin, C. A. [4 ]
Buckett, W. [5 ]
Lapensee, L. [6 ,7 ]
Kadoch, I. J. [6 ,7 ]
Gold, P. [1 ]
机构：
[1] McGill Univ, Montreal Gen Hosp, Dept Immunol, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Trio Fertil, Toronto, ON, Canada
[4] Univ Toronto, Dept Med & Obstet, Toronto, ON, Canada
[5] McGill Univ, Reprod Ctr, Montreal, PQ, Canada
[6] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada
[7] Ovo Clin, Dept Reprod Med, Montreal, PQ, Canada
来源：
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY | 2018年 / 45卷 / 05期
关键词：
Immunology; Infertility; Maternal-fetal medicine; PREGNANCY;
D O I：
10.12891/ceog4566.2018
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Intravenous Immunoglobulin (IVIg) is a potential treatment for immune mediated reproductive failure (IMRF), but its role in infertility treatments remains controversial. There is evidence that administering IVIg before conception improves pregnancy outcomes. In the present cohort, 13/15 (86%) patients had a live birth after receiving pre-conceptual Wig at immunomodulatory doses. No serious maternal or fetal side effects directly attributable to IVIg were reported. The present results support the need for a randomized controlled trial (RCT) with this protocol.
引用
收藏
页码：699 / 701
页数：3
相关论文
共 50 条
  • [1] Intravenous Immunoglobulin for Repeated IVF Failure and Unexplained Infertility
    Virro, Michael R.
    Winger, Edward E.
    Reed, Jane L.
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 68 (03) : 218 - 225
  • [2] Intravenous immunoglobulin (IVIG)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1249): : 101 - 103
  • [3] Scleromyxedema - A case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG)
    Blum, Marissa
    Wigley, Fredrick M.
    Hummers, Laura K.
    MEDICINE, 2008, 87 (01) : 10 - 20
  • [4] Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
    Mohtadi, Negar
    Ghaysouri, Abas
    Shirazi, Samira
    Ansari, Sara
    Shafiee, Elham
    Bastani, Elham
    Kokhazadeh, Taleb
    Tavan, Hamed
    VIROLOGY, 2020, 548 : 1 - 5
  • [5] Use of intravenous immunoglobulin G (IVIG)
    Looney, RJ
    Huggins, J
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (01) : 3 - 25
  • [6] PHARMACOKINETICS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN INFANTS
    WEISMAN, LE
    RODRIQUEZ, WJ
    KIM, HW
    BARON, PA
    FISCHER, GW
    PECK, CC
    HEMMING, VG
    PEDIATRIC RESEARCH, 1986, 20 (04) : A210 - A210
  • [7] Safety of intravenous immunoglobulin (IVIG) therapy
    Katz, Uriel
    Achiron, Anat
    Sherer, Yaniv
    Shoenfeld, Yehuda
    AUTOIMMUNITY REVIEWS, 2007, 6 (04) : 257 - 259
  • [8] A protocol for the desensitization to intravenous immunoglobulin (IVIg)
    Salomon, M.
    Hostoffer, R., Jr.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S180 - S180
  • [9] PHARMACOKINETICS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN NEONATES
    WEISMAN, LE
    FISCHER, GW
    HEMMING, VG
    PECK, CC
    PEDIATRIC RESEARCH, 1986, 20 (04) : A394 - A394
  • [10] INTRAVENOUS IMMUNOGLOBULIN (IVIG) HITS HIT
    Sanchez, Oriana
    San Luis, Christa
    Smalley, Zachary
    Farag, Nujud
    Sharma, Sameer
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 297 - 297
12345